Advertisement
| what is ahfs drug information: AHFS (R) DRUG INFORMATION 2021 AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS., 2021 |
| what is ahfs drug information: AHFS Drug Information 2019 Ashp, 2019 With the 2019 edition, the American Hospital Formulary Service® (AHFS®) marks its 61st year of continuous publication by the American Society of Health-System Pharmacists (ASHP). First published in 1959, the Formulary Service® has evolved to address increasingly complex issues related to drug therapy and formulary management.--Preface |
| what is ahfs drug information: AHFS Drug Information American Hospital Formulary Service, 2009 Being truly prepared means having the only compendium of evidence-based drug information at hand. the go-to book in pharmacies for more than 50 years, AHFS Drug Information is your trusted source when you need unbiased answers to critical questions. the only drug information resource published by a professional scientific association, AHFS offers the highest level of quality and trust that a drug guide can provide and gives the most expert, authoritative analysis to guide clinical decisions. |
| what is ahfs drug information: ASHP (R) INJECTABLE DRUG INFORMATION (TM), 2021 EDITION ASHP., 2020 |
| what is ahfs drug information: Description and Analysis of the VA National Formulary Institute of Medicine, Division of Health Care Services, VA Pharmacy Formulary Analysis Committee, 2000-11-03 The VA National Formulary generated controversy, which motivated congressional scrutiny and a directive to the VA to commission this report reviewing the experience with the National Formulary and formulary system. This Institute of Medicine committee was pleased to assist the Congress with this review, in part because the committee saw in the VHA example an opportunity to understand and anticipate problems that all publicly funded programs are likely to encounter in this new age of pharmaceuticals. The Congress asked the committee to review the restrictiveness of the National Formulary, its impact on the costs and quality of care in the VHA, and how it compared to formularies and drug management practices in the private sector and in other public programs, especially Medicaid. Detailed in the pages that follow, the committee's findings and conclusions on these questions are, the committee believes, highly instructive, though not always in the ways that we anticipated. |
| what is ahfs drug information: Drug-induced Diseases James E. Tisdale, 2010 Since the first edition of this book was published in 2005, drug therapy has seen both breakthrough advances and sobering setbacks. The changes will continue. That's why every health care professional, hospital and health system, pharmacy, and medical school needs this invaluable reference. It will help you detect, prevent and manage drug-related diseases. And also remind you to always ask yourself the increasingly critical question: Could this disease be drug-related? |
| what is ahfs drug information: Manual for Pharmacy Technicians Bonnie S. Bachenheimer, 2010-09-10 The trusted training resource for pharmacy technicians at all levels. The role of pharmacy technicians is rapidly expanding, and demand for well-trained technicians has never been higher! Technicians are assuming more responsibilities and are taking on greater leadership roles. Quality training material is increasingly important for new technicians entering the field, and current technicians looking to advance. Look no further than the new 4th edition of the best-selling Manual for Pharmacy Technicians to master the practical skills and gain the foundational knowledge all technicians need to be successful. NEW chapters cover the latest essentials: Specialty Pharmacy Practice Communication and Teamwork Billing and Reimbursement Durable and Nondurable Medical Equipment, Devices, and Supplies NEW features include: Full color design, photos and illustrations enhance learning Rx for Success boxes share tips to help techs excel on the job Technology Topics highlight the latest in automation & technical areas Safety First features provide critical advice for enhancing safety & reducing errors Bolded key terms defined in chapter-level glossaries Streamlined contents divide book into 4 simple parts: introduction to pharmacy practice, foundation knowledge and skills, practice basics, and business applications Expanded self-assessment questions and calculations content Alone or with the new edition of the Pharmacy Technician Certification Review and Practice Exam, the Manual for Pharmacy Technicians, 4th Edition offers pharmacy technicians the most relevant, authoritative, easy-to-use guide in the field. Want more exercises and practice? Look for the NEW Workbook for the Manual for Pharmacy Technicians. |
| what is ahfs drug information: Martindale Sean C. Sweetman, 2006-01-01 This is thirty-fifth edition of Martindale, which provides reliable, and evaluated information on drugs and medicines used throughout the world. It contains encyclopaedic facts about drugs and medicines, with: 5,500 drug monographs; 128,000 preparations; 40,700 reference citations; 10,900 manufacturers. There are synopses of disease treatments which enables identification of medicines, the local equivalent and the manufacturer. It also Includes herbals, diagnostic agents, radiopharmaceuticals, pharmaceutical excipients, toxins, and poisons as well as drugs and medicines. Based on published information and extensively referenced |
| what is ahfs drug information: Handbook on Injectable Drugs American Society of Health-System Pharmacists, 2018 ASHP's Guide to IV Compatibility & Stability Backed by quality, peer-reviewed published literature, the Handbook on Injectable Drugs(R) has been a go-to, trusted resource for more than four decades. Authored under the editorial authority of AHFS Drug Information(R) and published by ASHP, it's the global gold standard for IV compatibility and stability information. ASHP's Handbook on Injectable Drugs(R) is now newly updated with the latest information. The 20th edition features 27 new monographs, 23,663 compatibility pairs, and 276 new references. With its 40-year track record of precise, accurate detail, nothing else comes close for compatibility, stability, storage, and preparation of parenteral drugs. ASHP's Handbook on Injectable Drugs(R) is available in print and interactive formats. |
| what is ahfs drug information: Demystifying Drug Dosing in Renal Dysfunction Branden Nemecek, 2018-08-31 Chronic kidney disease affects approximately 10% of adults in the United States or approximately 20 million individuals. Further, recent studies have shown that improper dosing in patients with renal dysfunction occurs over 20% of the time. ASHP’s Demystifying Drug Dosing in Renal Dysfunction addresses the persistent and challenging problem of dosing medications for patients with renal insufficiency and dysfunction. |
| what is ahfs drug information: ASHP Injectable Drug Information American Society of Health-System Pharmacists, 2021-02-05 ASHP’s New and Expanded Guide to IV Compatibility & Stability For more than 40 years, ASHP has published the most trusted resource for injectable drug information. Our new ASHP® Injectable Drug Information™ now delivers the same high-quality content that you can expect from ASHP with even MORE of the information you need to make informed patient care decisions. For the first time ever, this gold standard reference is available as an eBook with new and expanded information. The 2021 edition features 18 new monographs, and nearly 200 new references for a total of over 24,000 total compatibility pairs. Backed by quality, peer-reviewed published literature, and authored under the editorial authority of ASHP, ASHP® Injectable Drug Information™ is a must-have resource for every pharmacy. |
| what is ahfs drug information: Drug Information Patrick M. Malone, Karen L. Kier, John Stanovich, 2010-05-12 Extensive coverage of the Internet as a source of and distribution means for drug information, and detailed sections on evaluating medical literature from clinical trials Audience includes Pharmacists, Pharmacy students and Pharmacy schools Updated to include using PDAs for medication information Covers the ethical and legal aspects of drug information management Nothing else like it on the market |
| what is ahfs drug information: AHFS Drug Information American Hospital Formulary Service, 2009 Being truly prepared means having the only compendium of evidence-based drug information at hand. the go-to book in pharmacies for more than 50 years, AHFS Drug Information is your trusted source when you need unbiased answers to critical questions. the only drug information resource published by a professional scientific association, AHFS offers the highest level of quality and trust that a drug guide can provide and gives the most expert, authoritative analysis to guide clinical decisions. |
| what is ahfs drug information: Drug Information Handbook Charles F. Lacy, Lora L. Armstrong, Morton P. Goldman, Leonard L. Lance, 2003 |
| what is ahfs drug information: Clinical Handbook of Psychotropic Drugs Kalyna Z. Bezchlibnyk-Butler, J. Joel Jeffries, 1989 Includes bibliography, glossary, and an extensive index which cross-references generic and trade names. New editions are available on a subscription basis. |
| what is ahfs drug information: Clinical Drug Data, 11th Edition Kelly Smith, Daniel M. Riche, Nickole Henyan, 2010-03-25 The best single resource available for evaluating and comparing more than 1200 commonly-used medications 4 STAR DOODY'S REVIEW! Although the primary audience for this book is practicing pharmacists, clinical pharmacists, pharmacy residents, and pharmacy students, the wide range of audiences who may benefit from this book include physicians and medical residents who may find this a useful resource, especially with the downloadable option....This is a useful and easy to use reference. Information is systematically organized in an easy to retrieve way.--Doody's Review Service ...will be useful to all health care professionals in a clinical setting. - Review of an earlier edition from the Australian Journal of Hospital Pharmacy Now includes PDA download of the entire text! Uniquely designed to allow comparisons within drug categories, Handbook of Clinical Drug Data is the most comprehensive, well-referenced book available on the selection, use, and clinical aspects of virtually any drug. Compiled by expert clinicians, this quick-access guide delivers the data you need to prevent adverse drug reactions in your patients and help you select drugs for both general and special patient populations Features Full-text PDA download More than 3800 literature citations Comparison charts of drugs by class facilitates clinical decision making Tables to help you rapidly identify the cause of adverse drug effects in patients Guidance on the optimal choice of drugs in special populations, including pregnant and breastfeeding women, and geriatric patients Genetic and ethic considerations Extensively cross-referenced index includes Canadian and British drug names Valuable appendices that include Conversion Factors, Anthropometrics, Laboratory Indices, Pharmacokinetic Equations, and more |
| what is ahfs drug information: AHFS Drug Information American Society of Health-System Pharmacists, 2014 Written and published by pharmacists and reviewed by over 500 experts, AHFS Drug Information® (AHFS DI) is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. The only print compendium designated by the US Congress, AHFS DI is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 55 years. 700,000 Adverse Drug Events occur every year. The majority of these are preventable. AHFS DI is a must-have resource to have at your fingertips. Its detailed and comprehensive drug monographs deliver valuable information and therapeutic guidelines to even the most complex questions. Don't waste time searching other references when you know you will always find the answer you can trust to be accurate inside-every time. Don't you owe it to yourself, your profession, and your patients? Inside find peer-reviewed monographs that cover: Expanded and revised content, featuring critical new monograph updates every year Interactions, adverse reactions, cautions, and more Therapeutic recommendations supported by evidence from primary research Preparations, chemistry, and stability Pharmacology and pharmacokinetics Prescription, OTC, ophthalmic and dermatologic drugs Extensive, off-label uses and dosing options Vaccines and other immunizing agents As always, there is a strong focus on safe and effective use of drugs. Hundreds of monographs have been updated for FDA's MedWatch alerts, risk evaluation mitigation strategies (REMS), and other critical safety information. Be sure to stay up to date with the latest medwatch alerts, new drug monographs, and updates, with your online access to AHFS Drug Information. Get access with the username and password found within the preface of the print book. |
| what is ahfs drug information: AHFS Drug Information, 1987 Gerald K. McEvoy, 1987-02-01 |
| what is ahfs drug information: The Chapter 800 Answer Book Patricia C. Kienle, 2017 Provides explanation of elements of USP Hazardous Drugs' Handling in Healthcare Settings and best practices to comply with the requirements and recommendations of the USP General Chapter--Pref. |
| what is ahfs drug information: Handbook of Non-prescription Drugs , 1995 |
| what is ahfs drug information: Pharmaceutical Toxicology Gerard J. Mulder, Lennart Dencker, 2006 Toxicology studies are carried out on all drug substances to ensure safety. This book provides an overview of the methodology andrequirements of pre-clinical safety assessments of new medicines. with the focus on medicinal drugs - the most important safety issues of drugs are covered, including registration requirements of new drugs and pharmacovigilance. This is an introductory text for students at BSc, MSc and PhD levels,and will be an excellent companion to pharmacology textbooks, combining a broad treatment of the issues relevant for assessing the safety/efficacy balance of a new drug wit |
| what is ahfs drug information: Competence Assessment Tools for Health-System Pharmacies Lee B. Murdaugh, 2007-09-01 Since its original publication, Competence Assessment Tools for Health-System Pharmacies has continued to meet the changing needs of pharmacy directors and their staff. Designed as a complete human resource competence assessment program, this benchmark resource ensures pharmacies comply with the competence assessment standards of The Joint Commission. Newly updated and revised, Competence Assessment provides practical tools to assess and document an employee’s ability to perform assigned duties and meet Joint Commission human resource requirements. Save time and increase efficiency with this essential tool that supplements and reinforces staff knowledge in key competency areas. |
| what is ahfs drug information: Handbook on Injectable Drugs Lawrence A. Trissel, 2001 |
| what is ahfs drug information: Drug Information Bonnie Snow, 1999 Designed for use as a self-study text, as a course text in more formal instruction programs, or as a refresher for the busy professional, the book includes valuable background data on legal and regulatory issues, as well as pharmaceutical technology. |
| what is ahfs drug information: AHFS Drug Information Gerald K. McEvoy, 2006 |
| what is ahfs drug information: Some Antiviral and Antineoplastic Drugs, and Other Pharmaceutical Agents IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2000 Evaluates the carcinogenic risks to humans posed by the use of four antiretroviral agents four DNA topoisomerase II inhibitors used in the treatment of cancer and an additional three pharmaceutical agents (hydroxyures phenolphthalein and vitamin K substances). The volume marks the first IARC evaluation of nucleoside analogs that act as antiviral agents. The evaluation responds in part to recent findings that zidovudine (AZT) an effective antiretroviral agent now being given to pregnant HIV-infected women to prevent maternal-to-fetal transmission of the virus is a transplacental carcinogen in mice. The opening monograph evaluates the carcinogenicity to humans of the antiretroviral nucleoside analogs zidovudine (AZT) zalcitabine (ddC) and didanosine (ddI) and the antiherpesvirus drug aciclovir. Of these aciclovir and didanosine could not be classified on the basis of available data. For zidovudine transplacental administration to mice resulted in an increased incidence and multiplicity of lung and liver tumours and in an increased incidence of female reproductive tract tumours in one study but not in another involving treatment at a lower dose. Despite observation of toxic effects in some studies of humans human carcinogenicity data were judged to provide inadequate evidence of carcinogenicity in humans. Zidovudine was classified as possibly carcinogenic to humans. Similar weaknesses in human carcinogenicity data for zalcitabine which consistently induces thymic lymphomas in mice resulted in its classification as possibly carcinogenic to humans. The second monograph evaluates four DNA topoisomerase II inhibitors: etoposide teniposide mitoxantrone and amsacrine. Of these etoposide - one of the most widely used and effective cytotoxic drugs in combination therapy - was classified as probably carcinogenic to humans and etoposide in combination with cisplatin and bleomycin was judged to be carcinogenic to humans. Teniposide was classified as probably carcinogenic to humans and mitoxantrone and amsacrine were classified as possibly carcinogenic to humans. Of the three pharmaceutical agents evaluated in the final monograph hydroxyurea which is widely used in cancer treatment and increasingly in combination with didanosine in HIV infection could not be classified. Phenolphthalein a widely used laxative now being withdrawn from the market in many countries because of toxicological concerns was classified as possibly carcinogenic. Vitamin K substances could not be classified on the basis of available evidence. |
| what is ahfs drug information: Pediatric Injectable Drugs Stephanie J. Phelps, Tracy M. Hagemann, Kelley R. Lee, A. Jill Thompson, 2013 For more than two decades, Pediatric Injectable Drugs (The Teddy Bear Book), has served an important and continuing need for reliable evidence-based information specific to pediatric injectable drugs. The tenth edition of this invaluable reference has grown to cover 238 drugs commonly used in the treatment of infants and children, including 20 new to this edition. |
| what is ahfs drug information: Extended Stability for Parenteral Drugs Caryn M. Bing, 2009 Extended Stability of Parenteral Drugs is an essential reference for anyone working in alternative site infusion practice. The 4th edition has been expanded and now includes 152 monographs that enable healthcare professionals to assign appropriate extended expiration dates, select the optimal container/administration system for drug compatibility, identify ideal storage conditions, and ensure flush compatibility. |
| what is ahfs drug information: Handbook of Institutional Pharmacy Practice Thomas R. Brown, Mickey C. Smith, 1986 |
| what is ahfs drug information: Pediatric Drug Formulations Milap Nahata, 2014-01-01 |
| what is ahfs drug information: Stockley's Drug Interactions 9 Ivan H. Stockley, 2010 |
| what is ahfs drug information: AHFS Drug Information 2012 American Society of Health-System Pharmacists, 2012 Annotation Written and published by pharmacists and reviewed by over 500 experts, AHFS Drug Informationr (AHFS DI) is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses. The only print compendium designated by the US Congress, AHFS DI is also the only reference published by a professional and scientific society - ensuring it is the most authoritative and best-selling reference trusted by pharmacists for 55 years. 700,000 Adverse Drug Events occur every year. The majority of these are preventable. AHFS DI is a must-have resource to have at your fingertips. Its detailed and comprehensive drug monographs deliver valuable information and therapeutic guidelines to even the most complex questions. Don't waste time searching other references when you know you will always find the answer you can trust to be accurate inside-every time. Don't you owe it to yourself, your profession, and your patients? Inside find peer-reviewed monographs that cover: * Expanded and revised content, featuring critical new monograph updates every year * Interactions, adverse reactions, cautions, and more * Therapeutic recommendations supported by evidence from primary research * Preparations, chemistry, and stability * Pharmacology and pharmacokinetics * Prescription, OTC, ophthalmic and dermatologic drugs * Extensive, off-label uses and dosing options * Vaccines and other immunizing agents As always, there is a strong focus on safe and effective use of drugs. Hundreds of monographs have been updated for FDA's MedWatch alerts, risk evaluation mitigation strategies (REMS), and other critical safety information. Be sure to stay up to date with the latest medwatch alerts, new drug monographs, and updates, with your online access to AHFS Drug Information. Get access with the username and password found within the preface of the print book. |
| what is ahfs drug information: Drug Information Handbook Lexicomp, 2013 Drug products alphabetically organized and cross-referenced by U.S. and Canadian brand names and index terms. |
| what is ahfs drug information: AHFS Drug Information , 1994 |
| what is ahfs drug information: Drug Information Handbook Charles F. Lacy, 1999 |
| what is ahfs drug information: Stockley's Herbal Medicines Interactions Elizabeth M. Williamson, 2009 This book contains data on over 150 of the most commonly used herbal medicines, dietary supplements and nutraceuticals. |
| what is ahfs drug information: Drug Information Handbook for Oncology Diedra L. Bragalone, 2017 |
| what is ahfs drug information: SANFORD GUIDE TO ANTIMICROBIAL THERAPY. , 2020 |
| what is ahfs drug information: Encyclopedia of Associations Verne Thompson, 2013-04-12 |
| what is ahfs drug information: AHFS Drug Information Essentials , 2016 |
Content Updates Archives - AHFS Drug Information
Mar 17, 2020 · The October update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of the update include: New PMI Monographs. Fosaprepitant Injection …
Current Products Archives - AHFS Drug Information
Just launched, AHFS Clinical Drug Information (AHFS CDI) is your comprehensive interactive treatment and drug therapy solution. It allows health professionals to quickly access the nation’s …
FDA Revokes EUA for Chloroquine and Hydroxychloroquine - AHFS …
On June 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate …
AHFS Patient Medication Information Update – May 2016
May 19, 2016 · The May update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of the update include: New PMI Monographs: Amphotericin B …
AHFS PMI Archives - Page 4 of 5 - AHFS Drug Information
Sep 22, 2016 · The July update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of the update include: New PMI Monographs: Uridine Triacetate …
AHFS, Author at AHFS Drug Information
Jun 1, 2022 · In the AHFS Essentials monograph, this statement should read: “Oral: 300 mg (two 150-mg tablets) once daily; use in combination with fulvestrant 500 mg by IM injection on days 1, …
AHFS Drug Information/Essentials Update – June 2017
Jun 5, 2017 · The June update to the AHFS Drug Information/Essentials database has been published. Highlights from this month’s update include: New AHFS/Essentials Monographs. New …
Spinraza (nusinersen) Approved - AHFS Drug Information
Dec 23, 2016 · FDA approves first drug for spinal muscular atrophy The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children …
AHFS, Author at AHFS Drug Information - Page 14 of 20
The October update to the AHFS Drug Information/Essentials database was published today. Highlights from this month’s update include: New AHFS/Essentials Monographs
Amjevita (adalimumab-atto) Approved - AHFS Drug Information
Sep 23, 2016 · FDA approves Amjevita, a biosimilar to Humira The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira …
Content Updates Archives - AHFS Drug Information
Mar 17, 2020 · The October update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of the update include: New PMI Monographs. Fosaprepitant …
Current Products Archives - AHFS Drug Information
Just launched, AHFS Clinical Drug Information (AHFS CDI) is your comprehensive interactive treatment and drug therapy solution. It allows health professionals to quickly access the …
FDA Revokes EUA for Chloroquine and Hydroxychloroquine
On June 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that allowed for chloroquine phosphate and hydroxychloroquine sulfate …
AHFS Patient Medication Information Update – May 2016
May 19, 2016 · The May update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of the update include: New PMI Monographs: Amphotericin B …
AHFS PMI Archives - Page 4 of 5 - AHFS Drug Information
Sep 22, 2016 · The July update to the AHFS Patient Medication Information (PMI) database has been published. Highlights of the update include: New PMI Monographs: Uridine Triacetate …
AHFS, Author at AHFS Drug Information
Jun 1, 2022 · In the AHFS Essentials monograph, this statement should read: “Oral: 300 mg (two 150-mg tablets) once daily; use in combination with fulvestrant 500 mg by IM injection on days …
AHFS Drug Information/Essentials Update – June 2017
Jun 5, 2017 · The June update to the AHFS Drug Information/Essentials database has been published. Highlights from this month’s update include: New AHFS/Essentials Monographs. …
Spinraza (nusinersen) Approved - AHFS Drug Information
Dec 23, 2016 · FDA approves first drug for spinal muscular atrophy The U.S. Food and Drug Administration today approved Spinraza (nusinersen), the first drug approved to treat children …
AHFS, Author at AHFS Drug Information - Page 14 of 20
The October update to the AHFS Drug Information/Essentials database was published today. Highlights from this month’s update include: New AHFS/Essentials Monographs
Amjevita (adalimumab-atto) Approved - AHFS Drug Information
Sep 23, 2016 · FDA approves Amjevita, a biosimilar to Humira The U.S. Food and Drug Administration today approved Amjevita (adalimumab-atto) as a biosimilar to Humira …
